leisure time -WSS

leisure time

author：Wikipedia 2025-09-27 19:28:38 - browse：467

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Washington mulls new rules to avert another Change Healthcare

hotspot

WSS

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

The Readout: Lenmeldy, GLP

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Supreme Court mifepristone arguments center on docs' right to sue

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

leisure time

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Washington mulls new rules to avert another Change Healthcare

BioMarin wins approval for gene therapy to treat hemophilia A

Steward Health Care has deal to sell doctor network to UnitedHealth

Activists slam private health insurers over coverage restrictions

Abortion pill Supreme Court ruling could impact entire drug industry

Heart attack and stroke risk calculators need revising

Readout LOUD podcast: mifepristone case, GLP

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout LOUD podcast: mifepristone case, GLP

leisure time

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

States should stop sabotaging methadone treatment reform

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

States should stop sabotaging methadone treatment reform

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

hotspot

hotspot

Wikipedia

hotspot